Wataru Hirose

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 24, 2024
Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma.

Hiroyuki Oshikiri, Keiko Taguchi, Wataru Hirose

Pageof 1

Frequent Collaborators

1 joint publications

Hiroyuki Oshikiri

1 joint publications

Keiko Taguchi

1 joint publications

Yusuke Taniyama

1 joint publications

Takashi Kamei